Andrew Cooper
Stock Analyst at Raymond James
(0.68)
# 4,121
Out of 4,639 analysts
206
Total ratings
40.5%
Success rate
-2.1%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Maintained: Buy | $105 | $87.22 | +20.39% | 14 | Aug 7, 2026 | |
| ITGR Integer Holdings | Downgraded: Hold | n/a | $125.04 | - | 7 | Aug 3, 2026 | |
| HCA HCA Healthcare | Reiterated: Hold | n/a | $411.44 | - | 1 | Jul 15, 2026 | |
| GH Guardant Health | Reiterated: Buy | $61 → $129 | $165.09 | -21.86% | 11 | Feb 23, 2026 | |
| MYGN Myriad Genetics | Maintained: Buy | $8 | $3.22 | +148.45% | 9 | Jan 13, 2026 | |
| AZTA Azenta | Reiterated: Buy | $35 → $45 | $33.39 | +34.77% | 4 | Nov 25, 2025 | |
| AVTR Avantor | Downgraded: Hold | n/a | $13.77 | - | 15 | Nov 4, 2025 | |
| RVTY Revvity | Reiterated: Buy | $115 | $115.73 | -0.63% | 8 | Oct 28, 2025 | |
| QDEL QuidelOrtho | Maintained: Buy | $60 → $55 | $13.99 | n/a | 28 | Aug 6, 2025 | |
| FLGT Fulgent Genetics | Reiterated: Buy | $25 | $19.00 | n/a | 4 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 → $535 | $605.00 | n/a | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $207.44 | n/a | 7 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $321.91 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.53 | n/a | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $175 | $312.72 | n/a | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $47.23 | n/a | 25 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.74 | n/a | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $46.41 | n/a | 9 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.88 | n/a | 14 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1,050 | $0.0001 | n/a | 11 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $30.51 | n/a | 2 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $586.64 | n/a | 3 | Feb 2, 2021 |
Haemonetics
Aug 7, 2026
Maintained: Buy
Price Target: $105
Current: $87.22
Upside: +20.39%
Integer Holdings
Aug 3, 2026
Downgraded: Hold
Price Target: n/a
Current: $125.04
Upside: -
HCA Healthcare
Jul 15, 2026
Reiterated: Hold
Price Target: n/a
Current: $411.44
Upside: -
Guardant Health
Feb 23, 2026
Reiterated: Buy
Price Target: $61 → $129
Current: $165.09
Upside: -21.86%
Myriad Genetics
Jan 13, 2026
Maintained: Buy
Price Target: $8
Current: $3.22
Upside: +148.45%
Azenta
Nov 25, 2025
Reiterated: Buy
Price Target: $35 → $45
Current: $33.39
Upside: +34.77%
Avantor
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $13.77
Upside: -
Revvity
Oct 28, 2025
Reiterated: Buy
Price Target: $115
Current: $115.73
Upside: -0.63%
QuidelOrtho
Aug 6, 2025
Maintained: Buy
Price Target: $60 → $55
Current: $13.99
Upside: n/a
Fulgent Genetics
Aug 4, 2025
Reiterated: Buy
Price Target: $25
Current: $19.00
Upside: n/a
Jul 24, 2025
Maintained: Buy
Price Target: $525 → $535
Current: $605.00
Upside: n/a
Jul 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $207.44
Upside: n/a
Mar 28, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $321.91
Upside: n/a
Feb 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $16.53
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $85 → $175
Current: $312.72
Upside: n/a
May 13, 2024
Downgraded: Hold
Price Target: n/a
Current: $47.23
Upside: n/a
Jul 18, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $4.74
Upside: n/a
Feb 22, 2023
Reiterated: Hold
Price Target: n/a
Current: $46.41
Upside: n/a
Feb 15, 2023
Maintained: Hold
Price Target: n/a
Current: $3.88
Upside: n/a
Feb 24, 2022
Maintained: Buy
Price Target: $1,050
Current: $0.0001
Upside: n/a
Feb 11, 2021
Reiterated: Hold
Price Target: n/a
Current: $30.51
Upside: n/a
Feb 2, 2021
Reiterated: Hold
Price Target: n/a
Current: $586.64
Upside: n/a